Fig. 5
From: Hyaluronate/black phosphorus complexes as a copper chelating agent for Wilson disease treatment
Cellular uptake and biocompatibility assessment of HA-DAH/BP complexes. a Confocal microscopy of HepG2 cells after treatment with FITC/BP and HA-FITC/BP complexes (scale bar = 50 μm) without and with HA pre-incubation (Blue: DAPI and Green: FITC). b The biocompatibility of BP nanosheets and HA-DAH/BP complexes in HepG2 cells by the CCK-8 assay (n = 4). Data are expressed as mean ± SD